A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Clinical trial NCT04426968 · COMPLETED
Trial details
- NCT number
- NCT04426968
- Sponsor
- Shanghai HEP Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-18
- Primary completion
- 2023-11-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.